<i>Lacticaseibacillus paracasei</i> 207-27 alters the microbiota–gut–brain axis to improve wearable device-measured sleep duration in healthy adults: a randomized, double-blind, placebo-controlled trial
Jinxing Li(Sichuan University), Jincheng Zhao(Sichuan University), Xiaolei Ze, Liang Li, Yapeng Li(Sichuan University), Zhimo Zhou(Sichuan University), Simou Wu(Sichuan University), Wen Jia(Sichuan University), Meixun Liu(Sichuan University), Yun Li(Sichuan University), Xi Shen(Sichuan University), Fang He(Sichuan University), Ruyue Cheng(Sichuan University)
Cited by 17Open Access
Abstract
207-27 administration in healthy adults resulted in improvements in gut microbiota community and sleep duration. The mechanisms might involve modulation of the gut microbiota structure to regulate the function of the gut-brain axis, including increases in SCFA levels and decreases in hypothalamic-pituitary-adrenal axis activity. The Chinese clinical trial registry number is ChiCTR2300069453 (https://www.chictr.org.cn/showproj.html?proj=191193, registered 16 May 2023 - retrospectively registered).
Related Papers
No related papers found
Powered by citation graph analysis